Literature DB >> 21974923

Targeted therapy of SMMC-7721 liver cancer in vitro and in vivo with carbon nanotubes based drug delivery system.

Zongfei Ji1, Gaofeng Lin, Qinghua Lu, Lingjie Meng, Xizhong Shen, Ling Dong, Chuanlong Fu, Xiaoke Zhang.   

Abstract

A new type of drug delivery system (DDS) involved chitosan (CHI) modified single walled carbon nanotubes (SWNTs) for controllable loading/release of anti-cancer doxorubicin (DOX) was constructed. CHI was non-covalently wrapped around SWNTs, imparting water-solubility and biocompatibility to the nanotubes. Folic acid (FA) was also bounded to the outer CHI layer to realize selective killing of tumor cells. The targeting DDS could effectively kill the HCC SMMC-7721 cell lines and depress the growth of liver cancer in nude mice, showing superior pharmaceutical efficiency to free DOX. The results of the blood routine and serum biochemical parameters, combined with the histological examinations of vital organs, demonstrating that the targeting DDS had negligible in vivo toxicity. Thus, this DDS is promising for high treatment efficacy and low side effects for future cancer therapy.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21974923     DOI: 10.1016/j.jcis.2011.09.013

Source DB:  PubMed          Journal:  J Colloid Interface Sci        ISSN: 0021-9797            Impact factor:   8.128


  29 in total

1.  Payload drug vs. nanocarrier biodegradation by myeloperoxidase- and peroxynitrite-mediated oxidations: pharmacokinetic implications.

Authors:  Wanji Seo; Alexandr A Kapralov; Galina V Shurin; Michael R Shurin; Valerian E Kagan; Alexander Star
Journal:  Nanoscale       Date:  2015-05-21       Impact factor: 7.790

2.  Development of medical-grade, discrete, multi-walled carbon nanotubes as drug delivery molecules to enhance the treatment of hematological malignancies.

Authors:  Carolyne Falank; Aaron W Tasset; Mariah Farrell; Sophie Harris; Paul Everill; Milos Marinkovic; Michaela R Reagan
Journal:  Nanomedicine       Date:  2019-06-04       Impact factor: 5.307

Review 3.  Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities.

Authors:  Umme Ruman; Sharida Fakurazi; Mas Jaffri Masarudin; Mohd Zobir Hussein
Journal:  Int J Nanomedicine       Date:  2020-03-03

4.  Advanced Functional Nanomaterials for Theranostics.

Authors:  Haoyuan Huang; Jonathan F Lovell
Journal:  Adv Funct Mater       Date:  2016-11-07       Impact factor: 18.808

5.  Photothermal cancer therapy by gold-ferrite nanocomposite and near-infrared laser in animal model.

Authors:  M Heidari; N Sattarahmady; N Azarpira; H Heli; A R Mehdizadeh; T Zare
Journal:  Lasers Med Sci       Date:  2015-12-22       Impact factor: 3.161

6.  Increased cellular uptake of lauryl gallate loaded in superparamagnetic poly(methyl methacrylate) nanoparticles due to surface modification with folic acid.

Authors:  Paulo Emilio Feuser; Juan Marcelo Carpio Arévalo; Enio Lima Junior; Gustavo Rodrigues Rossi; Edvaldo da Silva Trindade; Maria Eliane Merlin Rocha; Amanda Virtuoso Jacques; Eduardo Ricci-Júnior; Maria Claudia Santos-Silva; Claudia Sayer; Pedro H Hermes de Araújo
Journal:  J Mater Sci Mater Med       Date:  2016-10-27       Impact factor: 3.896

7.  Fabrication and characterization of a folic acid-bound 5-fluorouracil loaded quantum dot system for hepatocellular carcinoma targeted therapy.

Authors:  Xiaoxin Shi; Dongxiu He; Guotao Tang; Qian Tang; Runde Xiong; Hu Ouyang; Cui-Yun Yu
Journal:  RSC Adv       Date:  2018-05-29       Impact factor: 4.036

8.  Fucosylated multiwalled carbon nanotubes for Kupffer cells targeting for the treatment of cytokine-induced liver damage.

Authors:  Richa Gupta; Neelesh Kumar Mehra; Narendra Kumar Jain
Journal:  Pharm Res       Date:  2013-09-17       Impact factor: 4.200

9.  PEGylated single-walled carbon nanotubes as nanocarriers for cyclosporin A delivery.

Authors:  Naghmeh Hadidi; Farzad Kobarfard; Nastaran Nafissi-Varcheh; Reza Aboofazeli
Journal:  AAPS PharmSciTech       Date:  2013-03-12       Impact factor: 3.246

10.  Functional enhancement of chitosan and nanoparticles in cell culture, tissue engineering, and pharmaceutical applications.

Authors:  Wenjuan Gao; James C K Lai; Solomon W Leung
Journal:  Front Physiol       Date:  2012-08-21       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.